2025-04-012026-03-312026-03-31false09224177CAMBRIDGESHIRE ENDODONTIC CARE LIMITED2026-07-08falseiso4217:GBPxbrli:pure092241772025-03-31092241772026-03-31092241772025-04-012026-03-31092241772023-09-30092241772025-03-31092241772023-10-012025-03-3109224177bus:SmallEntities2025-04-012026-03-3109224177bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3109224177bus:FullAccounts2025-04-012026-03-3109224177bus:PrivateLimitedCompanyLtd2025-04-012026-03-3109224177core:WithinOneYear2026-03-3109224177core:AfterOneYear2026-03-3109224177core:WithinOneYear2025-03-3109224177core:AfterOneYear2025-03-3109224177core:ShareCapital2026-03-3109224177core:SharePremium2026-03-3109224177core:RevaluationReserve2026-03-3109224177core:OtherReservesSubtotal2026-03-3109224177core:RetainedEarningsAccumulatedLosses2026-03-3109224177core:ShareCapital2025-03-3109224177core:SharePremium2025-03-3109224177core:RevaluationReserve2025-03-3109224177core:OtherReservesSubtotal2025-03-3109224177core:RetainedEarningsAccumulatedLosses2025-03-3109224177core:LandBuildings2026-03-3109224177core:PlantMachinery2026-03-3109224177core:Vehicles2026-03-3109224177core:FurnitureFittings2026-03-3109224177core:OfficeEquipment2026-03-3109224177core:NetGoodwill2026-03-3109224177core:IntangibleAssetsOtherThanGoodwill2026-03-3109224177core:ListedExchangeTraded2026-03-3109224177core:UnlistedNon-exchangeTraded2026-03-3109224177core:LandBuildings2025-03-3109224177core:PlantMachinery2025-03-3109224177core:Vehicles2025-03-3109224177core:FurnitureFittings2025-03-3109224177core:OfficeEquipment2025-03-3109224177core:NetGoodwill2025-03-3109224177core:IntangibleAssetsOtherThanGoodwill2025-03-3109224177core:ListedExchangeTraded2025-03-3109224177core:UnlistedNon-exchangeTraded2025-03-3109224177core:LandBuildings2025-04-012026-03-3109224177core:PlantMachinery2025-04-012026-03-3109224177core:Vehicles2025-04-012026-03-3109224177core:FurnitureFittings2025-04-012026-03-3109224177core:OfficeEquipment2025-04-012026-03-3109224177core:NetGoodwill2025-04-012026-03-3109224177core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3109224177core:ListedExchangeTraded2025-04-012026-03-3109224177core:UnlistedNon-exchangeTraded2025-04-012026-03-3109224177core:MoreThanFiveYears2025-04-012026-03-3109224177core:Non-currentFinancialInstruments2026-03-3109224177core:Non-currentFinancialInstruments2025-03-3109224177dpl:CostSales2025-04-012026-03-3109224177dpl:DistributionCosts2025-04-012026-03-3109224177core:LandBuildings2025-04-012026-03-3109224177core:PlantMachinery2025-04-012026-03-3109224177core:Vehicles2025-04-012026-03-3109224177core:FurnitureFittings2025-04-012026-03-3109224177core:OfficeEquipment2025-04-012026-03-3109224177dpl:AdministrativeExpenses2025-04-012026-03-3109224177core:NetGoodwill2025-04-012026-03-3109224177core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3109224177dpl:GroupUndertakings2025-04-012026-03-3109224177dpl:ParticipatingInterests2025-04-012026-03-3109224177dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3109224177core:ListedExchangeTraded2025-04-012026-03-3109224177dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3109224177core:UnlistedNon-exchangeTraded2025-04-012026-03-3109224177dpl:CostSales2023-10-012025-03-3109224177dpl:DistributionCosts2023-10-012025-03-3109224177core:LandBuildings2023-10-012025-03-3109224177core:PlantMachinery2023-10-012025-03-3109224177core:Vehicles2023-10-012025-03-3109224177core:FurnitureFittings2023-10-012025-03-3109224177core:OfficeEquipment2023-10-012025-03-3109224177dpl:AdministrativeExpenses2023-10-012025-03-3109224177core:NetGoodwill2023-10-012025-03-3109224177core:IntangibleAssetsOtherThanGoodwill2023-10-012025-03-3109224177dpl:GroupUndertakings2023-10-012025-03-3109224177dpl:ParticipatingInterests2023-10-012025-03-3109224177dpl:GroupUndertakingscore:ListedExchangeTraded2023-10-012025-03-3109224177core:ListedExchangeTraded2023-10-012025-03-3109224177dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-10-012025-03-3109224177core:UnlistedNon-exchangeTraded2023-10-012025-03-3109224177core:NetGoodwill2026-03-3109224177core:IntangibleAssetsOtherThanGoodwill2026-03-3109224177core:LandBuildings2026-03-3109224177core:PlantMachinery2026-03-3109224177core:Vehicles2026-03-3109224177core:FurnitureFittings2026-03-3109224177core:OfficeEquipment2026-03-3109224177core:AfterOneYear2026-03-3109224177core:WithinOneYear2026-03-3109224177core:ListedExchangeTraded2026-03-3109224177core:UnlistedNon-exchangeTraded2026-03-3109224177core:ShareCapital2026-03-3109224177core:SharePremium2026-03-3109224177core:RevaluationReserve2026-03-3109224177core:OtherReservesSubtotal2026-03-3109224177core:RetainedEarningsAccumulatedLosses2026-03-3109224177core:NetGoodwill2025-03-3109224177core:IntangibleAssetsOtherThanGoodwill2025-03-3109224177core:LandBuildings2025-03-3109224177core:PlantMachinery2025-03-3109224177core:Vehicles2025-03-3109224177core:FurnitureFittings2025-03-3109224177core:OfficeEquipment2025-03-3109224177core:AfterOneYear2025-03-3109224177core:WithinOneYear2025-03-3109224177core:ListedExchangeTraded2025-03-3109224177core:UnlistedNon-exchangeTraded2025-03-3109224177core:ShareCapital2025-03-3109224177core:SharePremium2025-03-3109224177core:RevaluationReserve2025-03-3109224177core:OtherReservesSubtotal2025-03-3109224177core:RetainedEarningsAccumulatedLosses2025-03-3109224177core:NetGoodwill2023-09-3009224177core:IntangibleAssetsOtherThanGoodwill2023-09-3009224177core:LandBuildings2023-09-3009224177core:PlantMachinery2023-09-3009224177core:Vehicles2023-09-3009224177core:FurnitureFittings2023-09-3009224177core:OfficeEquipment2023-09-3009224177core:AfterOneYear2023-09-3009224177core:WithinOneYear2023-09-3009224177core:ListedExchangeTraded2023-09-3009224177core:UnlistedNon-exchangeTraded2023-09-3009224177core:ShareCapital2023-09-3009224177core:SharePremium2023-09-3009224177core:RevaluationReserve2023-09-3009224177core:OtherReservesSubtotal2023-09-3009224177core:RetainedEarningsAccumulatedLosses2023-09-3009224177core:AfterOneYear2025-04-012026-03-3109224177core:WithinOneYear2025-04-012026-03-3109224177core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3109224177core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3109224177core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3109224177core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3109224177core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3109224177core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3109224177core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3109224177core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3109224177core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3109224177core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3109224177core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3109224177core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3109224177core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3109224177core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3109224177core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3109224177core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3109224177core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3109224177core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3109224177core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3109224177core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3109224177core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3109224177core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3109224177core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3109224177core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3109224177core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3109224177core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3109224177core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3109224177bus:Director12025-04-012026-03-31

CAMBRIDGESHIRE ENDODONTIC CARE LIMITED

Registered Number
09224177
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

CAMBRIDGESHIRE ENDODONTIC CARE LIMITED
Company Information
for the year from 1 April 2025 to 31 March 2026

Director

Dr. Patrick Abbott

Registered Address

52 Downham Road
Ely
CB6 1BL

Registered Number

09224177 (England and Wales)
CAMBRIDGESHIRE ENDODONTIC CARE LIMITED
Balance Sheet as at
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets311,06425,901
11,06425,901
Current assets
Debtors424,21450,024
Cash at bank and on hand36,45819,118
60,67269,142
Creditors amounts falling due within one year5(55,905)(69,158)
Net current assets (liabilities)4,767(16)
Total assets less current liabilities15,83125,885
Creditors amounts falling due after one year6(6,981)(17,465)
Provisions for liabilities8(2,712)(6,475)
Net assets6,1381,945
Capital and reserves
Called up share capital100100
Profit and loss account6,0381,845
Shareholders' funds6,1381,945
The financial statements were approved and authorised for issue by the Director on 8 July 2026, and are signed on its behalf by:
Dr. Patrick Abbott
Director
Registered Company No. 09224177
CAMBRIDGESHIRE ENDODONTIC CARE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number is 09224177 and registered office address 52 Downham Road, Ely, Cambridgeshire, CB6 1BL
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Plant and machinery4
Vehicles4
Office Equipment4
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
2.Average number of employees

20262025
Average number of employees during the year32
3.Tangible fixed assets

Plant & machinery

Vehicles

Office Equipment

Total

££££
Cost or valuation
At 01 April 254,35858,1892,12764,674
At 31 March 264,35858,1892,12764,674
Depreciation and impairment
At 01 April 254,07833,0401,65538,773
Charge for year16014,54713014,837
At 31 March 264,23847,5871,78553,610
Net book value
At 31 March 2612010,60234211,064
At 31 March 2528025,14947225,901
4.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables22,72220,464
Other debtors1,49229,560
Total24,21450,024
As at the balance sheet date of 31 March 2026, other debtors comprise the following: Director's loan account :£1,491.53
5.Creditors: amounts due within one year

2026

2025

££
Taxation and social security44,07158,896
Finance lease and HP contracts9,8389,838
Other creditors1,996424
Total55,90569,158
As at the balance sheet date of 31 March 2026, other creditors comprise the following: Accruals :£480.00 Net wages : £1,446.00 Barclaycard : £69.99
6.Creditors: amounts due after one year

2026

2025

££
Other creditors6,98117,465
Total6,98117,465
As at the balance sheet date of 31 March 2026, other creditors comprise the following: Finance lease and HP contracts more than 1 year :£6,980.82
7.Obligations under finance leases

2026

2025

££
Finance lease and HP contracts16,81927,302
8.Provisions for liabilities

2026

2025

££
Net deferred tax liability (asset)2,7126,475
Total2,7126,475
9.Share capital
As at 31 March 2026, the company had issued 100 ordinary shares of £1 each, all paid. There has been no change in the share capital since the previous year end (31 March 2025).
10.Change in reporting period and impact on comparability
The financial statements for the year ended 31 March 2026 cover a period of 12 months from 1 April 2025 to 31 March 2026. The comparative figures presented for the previous period relate to an extended accounting period of 18 months from 1 October 2023 to 31 March 2025. Accordingly, the comparative amounts are not directly comparable with those of the current year.